In Brief: Ergo Science's Ergoset
Executive Summary
Ergo Science's Ergoset: Company expects to file NDA for Ergoset (bromocriptine) for non-insulin dependent diabetes by mid-1997, Ergo announces Jan. 21. Regulatory consulting firm Oxford Research International will assist in the NDA's preparation...